JAYSON JUN: Open Payments
NPI 1760808240 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,161 in 236 payments from 19 companies in 2025. Trend: 2023 $2,619 · 2024 $4,424 · 2025 $5,161
Food & beverage: $5,155Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $827 |
| Neurocrine BioSciences, Inc. | 20 | $618 |
| Lundbeck LLC | 27 | $552 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $513 |
| Otsuka America Pharmaceutical, Inc. | 17 | $389 |
| Vanda Pharmaceuticals Inc. | 17 | $344 |
| Janssen Pharmaceuticals, Inc | 13 | $331 |
| Axsome Therapeutics, Inc. | 10 | $279 |
| E.R. Squibb & Sons, L.L.C. | 15 | $261 |
| Teva Pharmaceuticals USA, Inc. | 9 | $217 |
Products named: VRAYLAR, REXULTI, INGREZZA, CAPLYTA, FANAPT, INVEGA SUSTENNA, Auvelity, COBENFY.
Industry payments across CA — which companies pay providers there.
